HTG Molecular Diagnostics to Announce Third Quarter and Nine Months Ended September 30, 2018 Financial Results and Host Conference Call on Thursday, November 8
Conference Call & Webcast Details
Toll Free: 800-458-4121
Conference ID: 5881694
HTG is focused on next generation sequencing (NGS) based molecular profiling. The company’s proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. HTG’s customers use its technology to identify biomarkers important for precision medicine, to understand the clinical relevance of these discoveries, and ultimately to identify treatment options. Our mission is to empower precision medicine at the local level.
LifeSci Advisors, LLC
Phone: (617) 525-7754
Source: HTG Molecular Diagnostics, Inc.